Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
142 | PARP1 | poly(ADP-ribose) polymerase 1 | |
176 | ACAN | aggrecan | |
308 | ANXA5 | annexin A5 | |
353 | APRT | adenine phosphoribosyltransferase | |
960 | CD44 | CD44 molecule (IN blood group) | |
1040 | CDS1 | CDP-diacylglycerol synthase 1 | |
1116 | CHI3L1 | chitinase 3 like 1 | |
1462 | VCAN | versican | |
1464 | CSPG4 | chondroitin sulfate proteoglycan 4 | |
1634 | DCN | decorin |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
31926 | Idgf4 | Imaginal disc growth factor 4 | |
34978 | Idgf1 | Imaginal disc growth factor 1 | |
34979 | Idgf2 | Imaginal disc growth factor 2 | |
34981 | Idgf3 | Imaginal disc growth factor 3 | |
36614 | ttv | tout-velu | |
36868 | Idgf6 | Imaginal disc growth factor 6 | |
37104 | Idgf5 | Imaginal disc growth factor 5 |
Gene ID | Gene Symbol | Description | Source | Organism |
---|---|---|---|---|
398214 | ext1.L | exostosin glycosyltransferase 1 L homeolog | Xenopus laevis (African clawed frog) | |
399115 | ext1.S | exostosin glycosyltransferase 1 S homeolog | Xenopus laevis (African clawed frog) | |
448393 | ext1 | exostosin glycosyltransferase 1 | Xenopus tropicalis (tropical clawed frog) |
UniProt ID | Protein Name | Source |
---|---|---|
P09874 | Poly [ADP-ribose] polymerase 1 | |
P13611 | Versican core protein | |
P16070 | CD44 antigen | |
P16112 | Aggrecan core protein | |
P16278 | Beta-galactosidase | |
P19320 | Vascular cell adhesion protein 1 | |
P34741 | Syndecan-2 | |
P35354 | Prostaglandin G/H synthase 2 | |
P42338 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | |
P43490 | Nicotinamide phosphoribosyltransferase |
HPO ID | HPO Term |
---|---|
HP:0001442 | Typified by somatic mosaicism |
HP:0006765 | Chondrosarcoma |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024